Gu YF, Lin FP, Epstein RJ. How aging of the global population is changing oncology. Ecancermedicalscience. 2021;15:ed119.
Article PubMed PubMed Central Google Scholar
Kleyn CE, Lai-Cheong JE, Bell HK. Cutaneous manifestations of internal malignancy. Am J Clin Dermatol. 2006;7:71–84.
Estape T. Cancer in the elderly: Challenges and barriers. Asia-Pac J Oncol Nurs. 2018;5:40–2.
Article PubMed PubMed Central Google Scholar
Lodi M, Scheer L, Reix N, Heitz D, Carin A-J, Thiébaut N, et al. Breast cancer in elderly women and altered clinico-pathological characteristics: A systematic review. Breast Cancer Res Treat. 2017;166:657–68.
Article PubMed CAS Google Scholar
Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP. Breast cancer among the oldest old: Tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;28:2038–45.
Article PubMed PubMed Central Google Scholar
Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol. 2007;25:869–75.
Herck YV, Feyaerts A, Alibhai S, Papamichael D, Decoster L, Lambrechts Y, et al. Is cancer biology different in older patients? Lancet Heal Longev. 2021;2:e663–77.
Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015;33:1453–9.
Mohile SG, Fan L, Reeve E, Jean-Pierre P, Mustian K, Peppone L, et al. Association of cancer with geriatric syndromes in older medicare beneficiaries. J Clin Oncol. 2011;29:1458–64.
Article PubMed PubMed Central Google Scholar
Gurney J, Sarfati D, Stanley J. The impact of patient comorbidity on cancer stage at diagnosis. Br J Cancer. 2015;113:1375–80.
Article PubMed PubMed Central CAS Google Scholar
Hurria A, Lichtman SM. Clinical pharmacology of cancer therapies in older adults. Br J Cancer. 2008;98:517–22.
Article PubMed PubMed Central CAS Google Scholar
Brenner S, Tamir E, Maharshak N, Shapira J. Cutaneous manifestations of internal malignancies. Clin Dermatol. 2001;19:290–7.
Article PubMed CAS Google Scholar
Pipkin CA, Lio PA. Cutaneous manifestations of internal malignancies: An overview. Dermatol Clin. 2008;26:1–15.
Article PubMed CAS Google Scholar
da Silva JA, de Mesquita KC, de Igreja ACSM, Lucas ICRN, Freitas AF, de Oliveira SM, et al. Paraneoplastic cutaneous manifestations: Concepts and updates*. An Bras Dermatol. 2012;88:09–22.
Dittmer M, Liu V. Dermato-oncology study guide, essential text and review. Springer International Publishing; 2021. pp. 41–71.
Laskaris G, Scully C, Tatakis DN. Periodontal manifestations of local and systemic diseases, color atlas and text. Berlin: Springer; 2023. pp. 211–4.
Boyce S, Harper J. Paraneoplastic dermatoses. Dermatol Clin. 2002;20:523–32.
Chung VQ, Moschella SL, Zembowicz A, Liu V. Clinical and pathologic findings of paraneoplastic dermatoses. J Am Acad Dermatol. 2006;54:745–62.
Arellano J, Iglesias P, Suarez C, Corredoira Y, Schnettler K. Malignant acanthosis nigricans as a paraneoplastic manifestation of metastatic breast cancer. Int J Women’s Dermatol. 2019;5:183–6.
Yu Q, Li X-L, Ji G, Wang Y, Gong Y, Xu H, et al. Malignant acanthosis nigricans: An early diagnostic clue for gastric adenocarcinoma. World J Surg Oncol. 2017;15:208.
Article PubMed PubMed Central Google Scholar
Thiers BH, Sahn RE, Callen JP. Cutaneous manifestations of internal malignancy. CA A Cancer J Clin. 2009;59:73–98.
Oh CW, Yoon J, Kim CY. Malignant acanthosis nigricans associated with ovarian cancer. Case Rep Dermatol. 2010;2:103–9.
Article PubMed PubMed Central Google Scholar
Wang H-J, Hu SC-S. Malignant acanthosis nigricans. N Engl J Med. 2023;388:1031–1031.
Srinivasan S, Friedman LS, editors. Commons problems in gastroenterology. Sitaraman and Friedman’s essentials of gastroenterology. John Wiley & Sons; 2017.
Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Prim. 2017;3:17036.
Boyce M, Flower C. Tripe palms. N Engl J Med. 2022;387:355–355.
Barman B, Devi LP, Thakur BK, Raphael V. Tripe palms and acanthosis nigricans: A clue for diagnosis of advanced pancreatic adenocarcinoma. Indian Dermatol Online J. 2019;10:453–5.
Article PubMed PubMed Central Google Scholar
Bolognia JL, Schaffer JV, Serroni L. Dermatology. 5th ed. Elsevier; 2025.
Lee HC, Ker KJ, Chong W-S. Oral malignant acanthosis nigricans and tripe palms associated with renal urothelial carcinoma. JAMA Dermatol. 2015;151:1381.
Patel S, Zirwas M, English JC. Acquired palmoplantar keratoderma. Am J Clin Dermatol. 2007;8:1–11.
Chakraborty PP, Datta S, Mandal SK, Kumar M. Tripe palm: A cutaneous manifestation of gastric carcinoma. BMJ Case Rep. 2014;2014:bcr2014206004.
Article PubMed PubMed Central Google Scholar
Chen W-T, Chu C-H. Tripe palm: A paraneoplastic manifestation of gastric cancer. CMAJ. 2019;191:E366–E366.
Article PubMed PubMed Central Google Scholar
Sethwala AM. Tripe palms: A cutaneous manifestation of internal malignancy. Méd J Aust. 2017;207:281–281.
Kumar P, Mukundan MK, Sehrawat A, Sundriyal D. Tripe palms and malignant acanthosis nigricans: More than a diagnostic pointer. Cancer Rep. 2021;4:e1307.
Cohen PR, Grossman ME, Almeida L, Kurzrock R. Tripe palms and malignancy. J Clin Oncol. 1989;7:669–78.
Article PubMed CAS Google Scholar
Yim S-H, Hong D, Jung KE, Seo Y-J, Lee Y. Hypertrichosis lanuginosa acquisita associated with autoimmune hepatitis. Ann Dermatol. 2021;33:200–2.
Article PubMed PubMed Central Google Scholar
Slee PHTJ, Waal RIFVD, van Leeuwen JHS, Tupker RA, Timmer R, Seldenrijk CA, et al. Paraneoplastic hypertrichosis lanuginosa acquisita: Uncommon or overlooked? Br J Dermatol. 2007;157:1087–92.
Article PubMed CAS Google Scholar
Russell P, Floridis J. Hypertrichosis lanuginosa acquisita: a rare dermatological disorder. Lancet. 2016;387:2035.
Comments (0)